EOB-MRI

DIAGNOSTIC_TEST2 trials

Sponsors

Seoul National University Hospital, Bayer

Conditions

Gadoxetate Sodium-enhanced Magnetic Resonance ImagingHepatocellular CarcinomaLiver MetastasesMetastatic Pancreatic Cancer

Unknown Phase

Evaluation of Diagnostic Accuracy of CEUS for HCC Diagnosis

Seoul National University HospitalHepatocellular Carcinoma

Start: 2018-10-16End: 2021-12-31Updated: 2021-03-17

An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions

CompletedNCT06106568

BayerGadoxetate Sodium-enhanced Magnetic Resonance Imaging, Liver Metastases, Metastatic Pancreatic Cancer

Start: 2023-11-20End: 2024-10-30Updated: 2024-11-04

Related Papers

Impact of EOB-MRI on the outcome of patients with pancreatic cancer in real-world settings.

Journal of Clinical Oncology2024-08-10